Julie M. Nauroth

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Takahiro Tsujikawa, Todd S. Crocenzi, Jennifer N. Durham et al. · Clinical Cancer Research · 2020 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

Mark Yarchoan, Chiung‐Yu Huang, Qingfeng Zhu et al. · Cancer Medicine · 2019 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Docosahexaenoic Acid (DHA) and Docosapentaenoic Acid (DPAn‐6) Algal Oils Reduce Inflammatory Mediators in Human Peripheral Mononuclear Cells In Vitro and Paw Edema In Vivo

Julie M. Nauroth, Ying Chun Liu, Mary Van Elswyk et al. · Lipids · 2010 · 89 citations

Life Sciences, Nutritional Sciences, Pharmacology +17

Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6)

Bindi Dangi, Marcus Obeng, Julie M. Nauroth et al. · Journal of Biological Chemistry · 2009 · 67 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein

Risaku Fukumoto, Vibeke Andresen, Izabela Bialuk et al. · Blood · 2008 · 55 citations

Life Sciences, Genetics, Molecular Biology +10